Basel Medical Group (BMGL)
Basel Medical Group Ltd is a Singapore-based healthcare provider listed on NASDAQ under the ticker BMGL. The company focuses on orthopedic care across general and subspecialized areas, including trauma and sports medicine, knee and hip replacement procedures, spine surgery, foot and ankle surgery, and minimally invasive orthopedic treatment. It also provides neurosurgical services, along with health screening, mental health, women’s health, and general practice services. Its operations further include medical consultations, diagnosis, and both medical and surgical treatment services. Incorporated in 2023, Basel Medical Group is headquartered in Singapore.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-BMGL
|
$6.29
|
36.4% Upside
|
Undervalued
|
Not available
|
Not available
|
Fair
|
0.0%
|
November 4, 2026
|
1.5x
|
0.6x
|
7.217 M
|
8.45 M
|
52.7%
|
32.0%
|
3.9
|
128.3%
|
